Advertisement

Topics

US FDA Drug Office Reform: 'Everything' Is On The Table

12:45 EST 15 Nov 2017 | SCRIP

Deputy Office of New Drugs director says IND evaluation and post-market surveillance could be part of restructuring effort along with...

      

Related Stories

 

Original Article: US FDA Drug Office Reform: 'Everything' Is On The Table

NEXT ARTICLE

More From BioPortfolio on "US FDA Drug Office Reform: 'Everything' Is On The Table"

Advertisement
Quick Search
Advertisement
Advertisement